Dr. James Lechleiter in the News for Astrocyte Pharmaceuticals Deal
Dr. James Lechleiter was featured in San Antonio Business Journal about UTHSCSA’s collaboration with Astrocyte Pharmaceuticals.
Under the agreement, Astrocyte Pharmaceuticals will have exclusive use of patent rights for a breakthrough therapeutic approach for brain trauma, such as traumatic brain injury and concussions, owned by the Health Science Center and developed by one of its research scientists, Dr. James Lechleiter.
Lechleiter expects that the scope of the Health Science Center’s research in brain trauma will also expand as Astrocyte Pharmaceuticals advances the neuroprotective therapy discovered in San Antonio.
“Right now, we are focused on the one patent and traumatic brain injury,” Dr. Lechleiter said in the article. “But we envision this also being an effective strategy potentially for strokes and degenerative diseases.”
To read the full article, click here.